title: [Triple therapy in the treatment of hepatitis C].
authors.forename: Javier
authors.initials: J
authors.lastname: Fernández-Castroagudín
authors.forename: Esther
authors.initials: E
authors.lastname: Molina-Pérez
mesh_terms: D000998:Antiviral Agents / Q000008:administration & dosage; D004359:Drug Therapy, Combination; D006526:Hepatitis C / Q000188:drug therapy*; D006801:Humans; D009842:Oligopeptides / Q000008:administration & dosage; D011392:Proline / Q000008:administration & dosage / Q000031:analogs & derivatives; D012254:Ribavirin / Q000008:administration & dosage
chemical_list: D000998:Antiviral Agents; D009842:Oligopeptides; D012254:Ribavirin; C486464:telaprevir; C512204:N-(3-amino-1-(cyclobutylmethyl)-2,3-dioxopropyl)-3-(2-((((1,1-dimethylethyl)amino)carbonyl)amino)-3,3-dimethyl-1-oxobutyl)-6,6-dimethyl-3-azabicyclo(3.1.0)hexan-2-carboxamide; D011392:Proline